drugset / Trial / NCT07571824
A Study to Assess the Bioavailability and Adhesion of Selegiline TDS in Healthy Subjects
RandomizedCrossoverSingle-blindTreatment
Summary
The purpose of this research study is to compare the bioavailability and adhesion of a generic Selegiline transdermal system (TDS) against the marketed comparator (EMSAM®) in healthy volunteers. Systemic and local safety and tolerability will be also observed and evaluated.
Timeline
- Start
- 2026-03-23
- Primary completion
- 2026-06-16
- Completion
- 2026-06-16
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Selegiline | Unknown | 6 mg | Other |
Indications
No indication recorded.